chr22-35406668-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006739.4(MCM5):​c.539C>G​(p.Thr180Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0778 in 1,611,746 control chromosomes in the GnomAD database, including 5,505 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.062 ( 385 hom., cov: 32)
Exomes 𝑓: 0.080 ( 5120 hom. )

Consequence

MCM5
NM_006739.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.169

Publications

24 publications found
Variant links:
Genes affected
MCM5 (HGNC:6948): (minichromosome maintenance complex component 5) The protein encoded by this gene is structurally very similar to the CDC46 protein from S. cerevisiae, a protein involved in the initiation of DNA replication. The encoded protein is a member of the MCM family of chromatin-binding proteins and can interact with at least two other members of this family. The encoded protein is upregulated in the transition from the G0 to G1/S phase of the cell cycle and may actively participate in cell cycle regulation. [provided by RefSeq, Jul 2008]
MCM5 Gene-Disease associations (from GenCC):
  • Meier-Gorlin syndrome 8
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0018073916).
BP6
Variant 22-35406668-C-G is Benign according to our data. Variant chr22-35406668-C-G is described in ClinVar as Benign. ClinVar VariationId is 1674156.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0846 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MCM5NM_006739.4 linkc.539C>G p.Thr180Ser missense_variant Exon 5 of 17 ENST00000216122.9 NP_006730.2 P33992B1AHB0
MCM5XM_006724242.5 linkc.539C>G p.Thr180Ser missense_variant Exon 5 of 18 XP_006724305.1
MCM5XM_047441366.1 linkc.539C>G p.Thr180Ser missense_variant Exon 5 of 18 XP_047297322.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MCM5ENST00000216122.9 linkc.539C>G p.Thr180Ser missense_variant Exon 5 of 17 1 NM_006739.4 ENSP00000216122.3 P33992

Frequencies

GnomAD3 genomes
AF:
0.0615
AC:
9368
AN:
152206
Hom.:
385
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0268
Gnomad AMI
AF:
0.00440
Gnomad AMR
AF:
0.0433
Gnomad ASJ
AF:
0.0271
Gnomad EAS
AF:
0.00501
Gnomad SAS
AF:
0.0758
Gnomad FIN
AF:
0.101
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0864
Gnomad OTH
AF:
0.0660
GnomAD2 exomes
AF:
0.0633
AC:
15779
AN:
249334
AF XY:
0.0664
show subpopulations
Gnomad AFR exome
AF:
0.0246
Gnomad AMR exome
AF:
0.0261
Gnomad ASJ exome
AF:
0.0267
Gnomad EAS exome
AF:
0.00288
Gnomad FIN exome
AF:
0.0948
Gnomad NFE exome
AF:
0.0836
Gnomad OTH exome
AF:
0.0685
GnomAD4 exome
AF:
0.0795
AC:
116059
AN:
1459422
Hom.:
5120
Cov.:
32
AF XY:
0.0799
AC XY:
58000
AN XY:
726150
show subpopulations
African (AFR)
AF:
0.0224
AC:
750
AN:
33478
American (AMR)
AF:
0.0289
AC:
1292
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0260
AC:
679
AN:
26132
East Asian (EAS)
AF:
0.00438
AC:
174
AN:
39700
South Asian (SAS)
AF:
0.0762
AC:
6576
AN:
86250
European-Finnish (FIN)
AF:
0.0946
AC:
4835
AN:
51116
Middle Eastern (MID)
AF:
0.0413
AC:
238
AN:
5758
European-Non Finnish (NFE)
AF:
0.0874
AC:
97188
AN:
1111900
Other (OTH)
AF:
0.0717
AC:
4327
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
5514
11027
16541
22054
27568
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3494
6988
10482
13976
17470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0615
AC:
9371
AN:
152324
Hom.:
385
Cov.:
32
AF XY:
0.0613
AC XY:
4562
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.0268
AC:
1115
AN:
41588
American (AMR)
AF:
0.0433
AC:
662
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0271
AC:
94
AN:
3470
East Asian (EAS)
AF:
0.00482
AC:
25
AN:
5182
South Asian (SAS)
AF:
0.0763
AC:
368
AN:
4826
European-Finnish (FIN)
AF:
0.101
AC:
1077
AN:
10614
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0864
AC:
5878
AN:
68026
Other (OTH)
AF:
0.0653
AC:
138
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
450
900
1351
1801
2251
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
116
232
348
464
580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0677
Hom.:
293
Bravo
AF:
0.0541
TwinsUK
AF:
0.0847
AC:
314
ALSPAC
AF:
0.0846
AC:
326
ESP6500AA
AF:
0.0275
AC:
121
ESP6500EA
AF:
0.0855
AC:
735
ExAC
AF:
0.0657
AC:
7971
Asia WGS
AF:
0.0330
AC:
113
AN:
3478
EpiCase
AF:
0.0792
EpiControl
AF:
0.0781

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

MCM5-related disorder Benign:1
Nov 25, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
14
DANN
Benign
0.87
DEOGEN2
Benign
0.043
T;T;.;T
Eigen
Benign
-0.73
Eigen_PC
Benign
-0.60
FATHMM_MKL
Benign
0.72
D
LIST_S2
Benign
0.42
T;T;T;T
MetaRNN
Benign
0.0018
T;T;T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
-1.0
N;.;.;.
PhyloP100
-0.17
PrimateAI
Benign
0.34
T
PROVEAN
Benign
0.12
N;N;N;N
REVEL
Benign
0.093
Sift
Benign
0.75
T;T;T;T
Sift4G
Benign
0.75
T;T;T;T
Polyphen
0.0
B;B;.;.
Vest4
0.082
MutPred
0.25
Gain of helix (P = 0.0425);.;.;.;
MPC
0.32
ClinPred
0.0010
T
GERP RS
0.20
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.2
Varity_R
0.036
gMVP
0.13
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2307340; hg19: chr22-35802661; COSMIC: COSV53349065; COSMIC: COSV53349065; API